ctrl K

Price Alert

SciClone Pharmaceuticals ... (SCLN)

NASDAQ: SCLN · Real-Time Price · USD

11.15

0.00 (0.00%)

At close: Jun 29, 2019, 12:07 AM

SciClone Pharmaceuticals Revenue Breakdown

Period Ending	Dec 31, 2016	Dec 31, 2015
Zadaxin Revenue	150.1M	146.1M
Zadaxin Revenue Growth	+2.74%	n/a

Revenue by Geography

Period Ending	Dec 31, 2016	Dec 31, 2015	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012
C Revenue	152.56M	151.57M	130.31M	122.62M	152.23M
C Revenue Growth	+0.65%	+16.32%	+6.28%	-19.45%	n/a
Rest Of World Including U.S. And Hong Kong Revenue	7.53M	5.68M	4.48M	n/a	n/a
Rest Of World Including U.S. And Hong Kong Revenue Growth	+32.53%	+26.90%	n/a	n/a	n/a

Operating Expense Breakdown

Period Ending	Jun 30, 2017	Mar 31, 2017	Dec 31, 2016	Sep 30, 2016	Jun 30, 2016	Mar 31, 2016	Dec 31, 2015	Sep 30, 2015	Jun 30, 2015	Mar 31, 2015
Selling, General, and Administrative Revenue	8.29M	7.23M	10.71M	7.9M	8.13M	7.44M	6.49M	7.29M	6.78M	7.34M
Selling, General, and Administrative Revenue Growth	+14.61%	-32.49%	+35.56%	-2.82%	+9.22%	+14.74%	-11.02%	+7.57%	-7.71%	n/a
Research and Development Revenue	2.83M	2.5M	5.56M	3.29M	2M	1.47M	3.61M	1.04M	5.5M	1.09M
Research and Development Revenue Growth	+13.35%	-55.11%	+69.04%	+64.40%	+36.33%	-59.32%	+247.06%	-81.11%	+405.51%	n/a
Sales and Marketing Revenue	15.44M	12.77M	14.6M	13.32M	14.43M	12.35M	14.86M	15.08M	12.96M	11.06M
Sales and Marketing Revenue Growth	+20.92%	-12.57%	+9.61%	-7.71%	+16.84%	-16.89%	-1.42%	+16.30%	+17.25%	n/a